| Pharma and healthcare sector faces M&A activity, cost cutting and impact on earnings |
Back |
| A feature of the year across the board will undoubtedly be cost cutting exercises, rationalisation of facilities and out sourcing of non-core activities as all major companies seek to maintain some earnings growth in 2009 writes Ian Hunter, ‘Best Pharma & Biotech Analyst’. |
.
.
.
Access to this article is restricted to subscribers.
Please enter your email address and password and then click the button below:
|
|
